Drug Profile
Interferon beta-1a biosimilar high-dose - CinnaGen
Alternative Names: Rec Hu-IFN beta 1a-44 microgram; ReciGenLatest Information Update: 23 Dec 2021
Price :
$50
*
At a glance
- Originator CinnaGen
- Class Antiasthmatics; Antineoplastics; Antivirals; Interferons; Vascular disorder therapies
- Mechanism of Action Interferon beta stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Multiple sclerosis
Most Recent Events
- 31 Dec 2013 Launched for Multiple sclerosis in Syria (SC)
- 31 Dec 2012 Registered for Multiple sclerosis in Syria (SC)
- 31 Dec 2009 Launched for Multiple sclerosis in Iran (SC)